Can Traditional CER Address Resource Allocation?

While the growth in U.S. healthcare costs is receiving substantial attention, many believe that instead of looking at general contributors, i.e. pharmaceutical pricing, we should look to resource allocation. Could Comparative Effectiveness Research (CER) methods help to answer this or is something different needed? Learn more here. (Source: Robert W Dubois, Future Medicine, Nov 2016)

You might also be interested in:

Dubois: One Group for Drug Assessments is Insufficient 07/22/2019
PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
NPC's Dubois: ICER Changes Benefit Payers, Not Patients 10/04/2019
NPC's Dubois: Article's Authors 'Used Flawed Data' 03/13/2019
Article on Drug Prices Spurs Debate 03/16/2019
Report: Employers Absorbing More Rebates from PBMs 03/13/2019
Leveraging Technology to Reduce Costs in Clinical Trials 06/30/2019